Skip to Content

Neurologic Involvement Common in Children Hospitalized With COVID-19

MONDAY, March 8, 2021 -- For children with COVID-19-related hospitalization, neurologic involvement is common and is usually transient, according to a study published online March 5 in JAMA Neurology.

Kerri L. LaRovere, M.D., from Boston Children's Hospital, and colleagues examined the range and severity of neurologic involvement associated with severe acute respiratory syndrome coronavirus 2 in children and adolescents in a case series of patients hospitalized with acute COVID-19 or multisystem inflammatory syndrome in children (MIS-C) between March 15 and December 15, 2020. Data were included for 1,695 patients at 61 U.S. hospitals.

The researchers found that 365 patients (22 percent) from 52 sites had documented neurologic involvement. Compared with those without neurologic involvement, patients with neurologic involvement were more likely to have underlying neurologic disorders (22 versus 8 percent); a similar number were previously healthy (53 versus 54 percent) and met criteria for MIS-C (35 versus 37 percent). Eighty-eight percent of those with neurologic involvement had transient symptoms and survived, while 12 percent developed life-threatening conditions that were clinically adjudicated to be associated with COVID-19, including severe encephalopathy, stroke, central nervous system infection/demyelination, Guillain-Barré syndrome/variants, and acute fulminant cerebral edema. Those with life-threatening neurologic conditions had higher neutrophil-to-lymphocyte ratios and higher reported frequency of D-dimer greater than 3 µg/mL fibrinogen equivalent units. Of the 43 patients who developed COVID-19-related life-threatening neurologic involvement, 11 patients died and 17 survivors had new neurologic deficits at hospital discharge.

"Future immunologic studies of cell-mediated and cytokine immune responses in young individuals may provide insight into the pathogenesis of neurologic disease in COVID-19 and MIS-C," the authors write.

Several authors disclosed financial ties to the pharmaceutical and medical technology industries.

Abstract/Full Text

© 2021 HealthDay. All rights reserved.

Read this next

Vaccinating Lactating Mothers May Protect Infants From COVID-19

WEDNESDAY, April 21, 2021 -- Antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are detectable in the breast milk of lactating women up to 80 days...

Mechanism ID'd for Thrombosis After ChAdOx1 nCoV-19 Vaccine

WEDNESDAY, April 21, 2021 -- A pathogenic platelet factor 4 (PF4)-dependent syndrome has been observed rarely after administration of the ChAdOx1 nCoV-19 vaccine, according to a...

Sex Disparities in COVID-19 Deaths Not Seen Across Race

WEDNESDAY, April 21, 2021 -- Sex disparities in COVID-19 mortality do not hold across racial groups, according to a study published online April 5 in the Journal of General...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.